← Back to Search

Behavioral Intervention

Study population for Cardiometabolic Syndrome

N/A
Recruiting
Led By Andrea Lopez-Cepero, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 4
Awards & highlights

Study Summary

This trial aims to see if a 4-week mindfulness program is feasible and well-received by young women in Puerto Rico experiencing high levels of stress. It will also investigate how the program affects participants'

Who is the study for?
This trial is for young women in Puerto Rico who are experiencing high levels of stress and may have cardiometabolic syndrome or metabolic issues. Participants should be willing to attend weekly virtual mindfulness sessions, do daily exercises at home, and fill out online questionnaires.Check my eligibility
What is being tested?
The study is testing a 4-week virtual mindfulness-based stress reduction program. It aims to see if this program is practical and well-received by the participants while measuring changes in their psychological resilience, distress, health behaviors, and markers related to heart health and metabolism.See study design
What are the potential side effects?
Since the intervention involves non-invasive practices like mindfulness exercises, significant side effects are not expected. However, some individuals might experience increased emotional sensitivity or mild discomfort as they engage with their thoughts during practice.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 4
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 4 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to the program
Rates of recruitment and retention
Ratings of satisfaction
Secondary outcome measures
Change in cardiometabolic markers: Blood Pressure
Change in cardiometabolic markers: Waist Circumference
Change in cardiometabolic markers: Weight

Trial Design

1Treatment groups
Experimental Treatment
Group I: Study populationExperimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Home exercises
2016
N/A
~340

Find a Location

Who is running the clinical trial?

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
485 Previous Clinical Trials
1,086,879 Total Patients Enrolled
Emory UniversityLead Sponsor
1,646 Previous Clinical Trials
2,564,570 Total Patients Enrolled
Andrea Lopez-Cepero, PhDPrincipal InvestigatorRollins School of Public Health
~20 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top